Skip to main content

Advances in Radiation Oncology

  • ISSN: 2452-1094

Editor-In-Chief: Jimenez

Next planned ship date: May 15, 2024

  • 5 Year impact factor: 2.5
  • Impact factor: 2.3

An official journal of the American Society for Radiation Oncology Advances in Radiation Oncology is a peer reviewed, wide-ranging open access journal from the American Soci… Read more

Subscription options

Next planned ship date:
May 15, 2024

Institutional subscription on ScienceDirect

Request a sales quote
An official journal of the American Society for Radiation Oncology

Advances in Radiation Oncology is a peer reviewed, wide-ranging open access journal from the American Society for Radiation Oncology (ASTRO). Included in PubMed Central, Advances complements the research in the International Journal of Radiation Oncology • Biology • Physics and Practical Radiation Oncology. The mission of Advances in Radiation Oncology is to provide original clinical research aimed at improving the lives of people living with cancer and other diseases treated with radiation therapy. The purpose of Advances is to provide information for clinicians who use radiation therapy by publishing:

Clinical trial reports and reanalyses.

Basic science original reports.

Manuscripts examining health services research, comparative and cost effectiveness research, and systematic reviews.

Case reports documenting unusual problems and solutions.

High quality multi and single institutional series, as well as other novel retrospective hypothesis generating series.

Timely critical reviews on important topics in radiation oncology, such as side effects.

Articles reporting the natural history of disease and patterns of failure, particularly as they relate to treatment volume delineation.

Articles on safety and quality in radiation therapy.

Essays on clinical experience.

Articles on practice transformation in radiation oncology, in particular:

Aspects of health policy that may impact the future practice of radiation oncology.

How information technology, such as data analytics and systems innovations, will change radiation oncology practice.

Articles on imaging as they relate to radiation therapy treatment.



Advances is a gold open access journal, so authors, readers and patients have free access to all articles. All work published by this journal is thoroughly peer reviewed by the editorial board and expert reviewers in radiation oncology. Authors retain copyright of their articles and reuse is governed under a Creative Commons license so that readers can freely and easily share information. Learn more about the types of articles sought by the editorial team.

Disclaimer
The views expressed in Advances in Radiation Oncology (the "Journal") are those of the individual authors and are not necessarily those of the American Society for Radiation Oncology (ASTRO) or the Publisher. The information contained in the Journal is not medical advice and is not intended to replace the judgment of a practitioner with respect to particular patients, procedures, or practice. No responsibility is assumed by the Publisher nor by the Society for any injury and/or damage to persons or property as a result of (i) any actual or alleged libelous statements or infringement of intellectual property or privacy rights, (ii) product liability or negligence; (iii) an author's statements or other materials; or (iv) the use or operation of any ideas, instructions, procedures, products, or methods contained in the Journal. Due to rapid advances in the medical sciences, independent verification of diagnoses and drug dosages should always be made. In any jurisdiction that does not permit such a disclaimer of liability, the liability of ASTRO and the Publisher shall be limited to the greatest extent allowed by applicable law.

Publication of an advertisement in the Journal does not constitute on the part of the Publisher or the Society a guarantee or endorsement of the quality or value of the advertised products or services described therein or of any of the representations or the claims made by the advertisers with respect to such products or services.